SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation

Recent data suggest that SRC family kinases (SFKs) could represent potential therapeutic targets for rhabdomyosarcoma (RMS), the most common soft-tissue sarcoma in children. Here, we assessed the effect of a recently developed selective SFK inhibitor (a pyrazolo[3,4-d]pyrimidine derivative, called S...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Casini, Nadia, Forte, Iris Maria, Mastrogiovanni, Gianmarco, Pentimalli, Francesca, Angelucci, Adriano, Festuccia, Claudio, Tomei, Valentina, Ceccherini, Elisa, Di Marzo, Domenico, Schenone, Silvia, Botta, Maurizio, Giordano, Antonio, Indovina, Paola
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494948/
https://ncbi.nlm.nih.gov/pubmed/25762618
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki